Loading company…
Cambridge, US-based clinical-stage biotech developing RNA medicines through its PRISM platform.
Based in Massachusetts, US, Wave Life Sciences Ltd., also known as Wave Life Sciences, was founded in 2012 by co-founder Greg Verdine. It is a clinical-stage biotechnology company that designs, develops and commercializes RNA medicines through its PRISM platform. In December 2023, the company raised USD 100 million in a private placement of 20 million shares at USD 5 per share on the Nasdaq Global Select Market under the ticker WVE. As of May 2024, Paul Bolno is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in